GlobalData on MSN21h
AstraZeneca lung cancer therapy Imfinzi recommended for EU approvalThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended AstraZeneca's Imfinzi ...
Zacks.com on MSN14h
CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's ImfinziJohnson & Johnson JNJ announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use ...
AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...
(IN BRIEF) AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for approval as a ...
HHM Wealth Advisors LLC grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 38.8% during the 4th ...
As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...
The U.K. government is defending its negotiations with AstraZeneca (AZN), after the pharmaceutical company dropped a planned $558M investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback